CIK 0001612042 · Large accelerated filer
Ascendis Pharma A/S
Sign in to watch- Ticker
- ASND
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Denmark
- Entity type
- other
- Phone
- 45 70 22 22 44
- Business address
- TUBORG BOULEVARD 12, HELLERUP, Denmark
- 4 Open-market sale See Remarks sold 19,460 shares at $238.49 ($4,641,021)
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 8-A12B/A Other Registration Statement
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 3 Insider Initial Statement of Ownership
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 3 of 40 · 799 filings